The Faculty of Health Sciences

Medicine & Life Sciences

1. Denmark 100%
2. Cohort Studies 56%
3. Population 44%
4. Randomized Controlled Trials 44%
5. Systematic Reviews 42%
6. Child 39%
7. Therapeutics 38%
8. Mortality 38%
9. Exercise 37%
10. Health 31%
11. Confidence Intervals 30%
12. Neoplasms 28%
13. Meta-Analysis 27%
14. Registries 27%
15. Pain 25%
16. Type 2 Diabetes Mellitus 22%
17. Cross-Sectional Studies 21%
18. Quality of Life 20%
19. Delivery of Health Care 20%
20. Low Back Pain 20%
21. Survival 20%
22. Genes 20%
23. Incidence 19%
24. Prospective Studies 19%
25. Twins 19%
26. Guidelines 17%
27. Breast Neoplasms 17%
28. Odds Ratio 17%
29. Biomarkers 17%
30. Parturition 16%
31. Pregnancy 16%
32. Placebos 16%
33. Depression 15%
34. Mutation 15%
35. Interviews 14%
36. Myocardial Infarction 14%
37. Databases 14%
38. Pharmaceutical Preparations 13%
39. Colorectal Neoplasms 13%
40. Mothers 13%
41. Knee Osteoarthritis 13%
42. Serum 13%
43. Muscles 13%
44. Bone and Bones 13%
45. Rheumatoid Arthritis 13%
46. Education 13%
47. Observational Studies 12%
48. Cardiovascular Diseases 12%
49. Body Mass Index 12%
50. Glucose 12%
51. Wounds and Injuries 12%
52. Patient Reported Outcome Measures 12%
53. Occupational Groups 12%
54. Infections 12%
55. Chronic Obstructive Pulmonary Disease 12%
56. Hip 11%
57. Rehabilitation 11%
58. Blood Pressure 11%
59. Alcohols 11%
60. Smoking 11%
61. Phenotype 11%
62. Asthma 11%
63. Kidney 11%
64. Knee 11%
65. Proteins 11%
66. Safety 11%
67. Obesity 11%
68. Comorbidity 10%
69. Multiple Sclerosis 10%
70. Atrial Fibrillation 10%
71. Type 1 Diabetes Mellitus 10%
72. Mental Health 10%
73. Greenland 10%
74. Elderly 10%
75. General Practitioners 10%
76. Recurrence 10%
77. Hypersensitivity 10%
78. Guinea-Bissau 10%
79. HIV 10%
80. Multicenter Studies 10%
81. Stroke 10%
82. Referral and Consultation 10%
83. Life Style 10%
84. Heart Failure 9%
85. Inflammation 9%
86. Primary Health Care 9%
87. General Practice 9%
88. Case-Control Studies 9%
89. Twin Studies 9%
90. Lung 9%
91. Anxiety 9%
92. Insulin 9%
93. Morbidity 9%
94. Drug Therapy 9%
95. Logistic Models 9%
96. Costs and Cost Analysis 9%
97. Radiotherapy 9%
98. Vaccination 9%
99. Longitudinal Studies 8%
100. Brain 8%